How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code DHX: System, Test, Carcinoembryonic Antigen. View classification details, related manufacturers, 510(k) clearances, and recall records.
28 clearance records and 9 recall records in the covered releases, across 27 source company names and 1 product codes. Dated history runs from Sep 26, 1980 to Sep 22, 2023.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| DHX · System, Test, Carcinoembryonic Antigen | 28 | 9 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Access CEAK223921 · DHX | Beckman Coulter, Inc. | 510(k) | Sep 22, 2023FDA decision date |
| VITROS Immunodiagnostic Products CEA Reagent PackK231517 · DHX | Ortho Clinical Diagnostics | 510(k) | Aug 23, 2023FDA decision date |
| ADVIA Centaur CEA AssayK200215 · DHX | Siemens Healthcare Disgnostics, Inc. | 510(k) | Apr 13, 2020FDA decision date |
| ST-AIA PACK CEA; Part Number: 025254 Assay, Tumor MarkerZ-2066-2018 · DHX | Tosoh Bioscience Inc | Recall | Jun 5, 2018FDA record creation date |
| IMMULITE /IMMULITE 1000 CEAZ-1678-2018 · DHX | Siemens Healthcare Diagnostics, Inc. | Recall | May 4, 2018FDA classification date |
| IMMULITE 2000/IMMULITE 2000 XPi CEAZ-1679-2018 · DHX | Siemens Healthcare Diagnostics, Inc. | Recall | May 4, 2018FDA classification date |
| Access CEA Assay, Part No. 33200. For the quantitative determination of Carcinoembryonic Antigen (CEA) levels in human serum.Z-0239-2016 · DHX | Beckman Coulter Inc. | Recall | Nov 6, 2015FDA classification date |
| CEA ELISA Kit. BioCheck, Foster City, CA 9440. Quantitative determination of AFP concentration in human serum.Z-1627-2011 · DHX | BioCheck Inc | Recall | Mar 11, 2011FDA classification date |
| OLYMPUS CEA - CARCINOEMBRYONIC ANTIGENK081615 · DHX | Olympus America, Inc. | 510(k) | Mar 18, 2009FDA decision date |
| VIDAS CEA (S) ASSAYK080194 · DHX | bioMerieux, Inc. | 510(k) | Oct 9, 2008FDA decision date |
| DIMENSION VISTA CARCINOEMBRYONIC ANTIGEN FLEX REAGENT CARTRIDGE (CEA)K071603 · DHX | Dade Behring, Inc. | 510(k) | Jun 25, 2008FDA decision date |
| Access Immunoassay system CEA, in vitro diagnostic, Part No. 33200Z-1313-06 · DHX | Beckman Coulter Inc | Recall | Aug 1, 2006FDA classification date |
| Immulite/ Immulite 1000 Carcinoembryonic Antigen (CEA) LKCE1 lot 302 and 303Z-1015-05 · DHX | Diagnostic Products Corp | Recall | Jul 16, 2005FDA classification date |
| Immulite 1000 CEA Catalog No. LKCE1Z-0972-04 · DHX | Diagnostic Products Corp | Recall | Jul 20, 2004FDA classification date |
| VITROS IMMUNODIAGNOSTIC PRODUCTS CEA REAGENT PACK/CALIBRATOR/RANGE VERIFIERSK041322 · DHX | Ortho-Clinical Diagnostics, Inc. | 510(k) | Jun 17, 2004FDA decision date |
| Vitros Immunodiagnostic Products CEA REAGENT PACK, Lot 750, REF 192 0115, 100 coated wells per pack. Firm on the label: Ortho-Clinical Diagnost…Z-0299-04 · DHX | Ortho-Clinical Diagnostics | Recall | Jan 6, 2004FDA classification date |
| ACCESS CEA REAGENTS FOR USE ON THE ACCESS IMMUNOASSAY SYSTEMSK031270 · DHX | Beckman Coulter, Inc. | 510(k) | May 6, 2003FDA decision date |
| ST AIA-PACK CEA ENZYME IMMUNOASSAYK023893 · DHX | Tosoh Medics, Inc. | 510(k) | Dec 18, 2002FDA decision date |
| CEA ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEMK013568 · DHX | Bayer Corp. | 510(k) | Dec 21, 2001FDA decision date |
| VITROS IMMUNODIAGNOSTIC PRODUCTS CEA CALIBRATORS, VITROS IMMUNODIAGNOSTIC PRODUCTS CEA REAGENT PACKK990943 · DHX | Ortho-Clinical Diagnostics, Inc. | 510(k) | Jun 1, 1999FDA decision date |
| MODIFICATION TO ACCESS CEA REAGENTS FOR USE ON THE ACCESS IMMUNOASSAY ANALYZER, MODELS 33200, 33205, 33209, 33206K991707 · DHX | Beckman | 510(k) | Jun 1, 1999FDA decision date |
| ABBOTT ARCHITECT CEAK990774 · DHX | Abbott Laboratories | 510(k) | May 11, 1999FDA decision date |
| ACCESS CEA REAGENTS ON THE ACCESS IMMUNOASSAY ANALYZER MODEL 33200, 33205, 33206 & 33209K981985 · DHX | Beckman Coulter, Inc. | 510(k) | Sep 24, 1998FDA decision date |
| ACS:CENTAUR CEAK981478 · DHX | Chiron Diagnostics Corp. | 510(k) | Aug 12, 1998FDA decision date |
| ELECSYS CEA ON THE ELECSYS 1010K980887 · DHX | Boehringer Mannheim Corp. | 510(k) | Jun 29, 1998FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.